Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1930 1
1933 1
1934 1
1935 1
1936 2
1937 2
1938 2
1939 3
1940 3
1941 3
1942 2
1945 1
1946 13
1947 2
1948 20
1949 18
1950 11
1951 8
1952 22
1953 4
1954 11
1955 17
1956 6
1957 10
1958 12
1959 10
1960 9
1961 5
1962 12
1963 8
1964 7
1965 15
1966 13
1967 8
1968 11
1969 7
1970 9
1971 15
1972 10
1973 15
1974 6
1975 15
1976 8
1977 12
1978 4
1979 9
1980 10
1981 5
1982 7
1983 10
1984 11
1985 11
1986 7
1987 2
1988 6
1989 10
1990 5
1991 11
1992 4
1993 7
1994 6
1995 8
1996 7
1997 8
1998 6
1999 7
2000 8
2001 12
2002 16
2003 15
2004 13
2005 14
2006 13
2007 21
2008 12
2009 9
2010 14
2011 17
2012 13
2013 20
2014 25
2015 17
2016 12
2017 13
2018 17
2019 26
2020 26
2021 49
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

888 results
Results by year
Filters applied: . Clear all
Page 1
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells.
Smith EL, Harrington K, Staehr M, Masakayan R, Jones J, Long TJ, Ng KY, Ghoddusi M, Purdon TJ, Wang X, Do T, Pham MT, Brown JM, De Larrea CF, Olson E, Peguero E, Wang P, Liu H, Xu Y, Garrett-Thomson SC, Almo SC, Wendel HG, Riviere I, Liu C, Sather B, Brentjens RJ. Smith EL, et al. Sci Transl Med. 2019 Mar 27;11(485):eaau7746. doi: 10.1126/scitranslmed.aau7746. Sci Transl Med. 2019. PMID: 30918115 Free PMC article.
IMI - Myopia Control Reports Overview and Introduction.
Wolffsohn JS, Flitcroft DI, Gifford KL, Jong M, Jones L, Klaver CCW, Logan NS, Naidoo K, Resnikoff S, Sankaridurg P, Smith EL 3rd, Troilo D, Wildsoet CF. Wolffsohn JS, et al. Among authors: smith el 3rd. Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M1-M19. doi: 10.1167/iovs.18-25980. Invest Ophthalmol Vis Sci. 2019. PMID: 30817825 Free PMC article.
Myopia control with novel central and peripheral plus contact lenses and extended depth of focus contact lenses: 2 year results from a randomised clinical trial.
Sankaridurg P, Bakaraju RC, Naduvilath T, Chen X, Weng R, Tilia D, Xu P, Li W, Conrad F, Smith EL 3rd, Ehrmann K. Sankaridurg P, et al. Among authors: smith el 3rd. Ophthalmic Physiol Opt. 2019 Jul;39(4):294-307. doi: 10.1111/opo.12621. Epub 2019 Jun 10. Ophthalmic Physiol Opt. 2019. PMID: 31180155 Free PMC article. Clinical Trial.
Reply.
Smith EL. Smith EL. Orthopedics. 2021 Sep-Oct;44(5):262-263. doi: 10.3928/01477447-20210819-11. Epub 2021 Sep 1. Orthopedics. 2021. PMID: 34590951 Free article. No abstract available.
Novel Immunotherapies for Multiple Myeloma.
D'Agostino M, Boccadoro M, Smith EL. D'Agostino M, et al. Among authors: smith el. Curr Hematol Malig Rep. 2017 Aug;12(4):344-357. doi: 10.1007/s11899-017-0397-7. Curr Hematol Malig Rep. 2017. PMID: 28819882 Free PMC article. Review.
Myopia--yesterday, today, and tomorrow.
Mutti DO, Gwiazda J, Norton TT, Smith EL 3rd, Schaeffel F, To CH. Mutti DO, et al. Among authors: smith el 3rd. Optom Vis Sci. 2013 Nov;90(11):1161-4. doi: 10.1097/OPX.0000000000000117. Optom Vis Sci. 2013. PMID: 24152883 Free PMC article. No abstract available.
888 results